Brit Mollenhauer, MD
Attending at Paracelsus-Elena-Klinik
Assistant Professor at University Medical Center, Goettingen
Location: Kassel, Germany
Brit Mollenhauer, MD, graduated with a medical degree in 2000 from Georg-August-University in Goettingen, Germany, where she also received residency training in neurology until 2005. Between 2005 and 2007, Dr. Mollenhauer studied biomarker development and cerebrospinal fluid alpha-synuclein as a postdoctoral fellow at Harvard Medical School.
Since June 2007 she has been assistant professor in Neurology at Georg-August-University in Goettingen, Germany and the Movement Disorder Paracelsus-Elena-Klinik in Kassel, Germany. She holds a degree in neurochemistry and established her own research team focusing on human body fluid biomarker detection and assay development for improving diagnosis of movement disorders. Dr. Mollenhauer established a single-center cohort on de novo PD and healthy controls and subjects with idiopathic REM sleep behavior disorder in Kassel (DeNoPa-cohort), which is followed biannually. She has published more than 70 original research and 20 review articles and is a member of the executive steering committee of the Parkinsonís Progression Markers Initiative from The Michael J. Fox Foundation.
- Microbiome Biomarkers for Early-stage Detection and Stratification of Parkinson's Disease (2017)
- Alpha-Synuclein Assay Standardization LEAPS (2014)
- Characterization and Validation of Disease-specific Alpha-synuclein Species in Cerebrospinal Fluid (2014)
- Validation and Characterization of Exosomal Alpha-synuclein as a Diagnostic Marker for Parkinsonís Disease (2013)
- A New Tool for CSF-Based Parkinson Disease Diagnostics: Super-Resolution Microscopy Investigation of Alpha-Synuclein Aggregates (2013)
- Laboratory Phenotyping of Parkinson Disease Subjects Using a Multiplex Approach (2011)
- Validation of CSF Alpha-synuclein as a Biomarker for Parkinson's disease (2007)